AndrewPollard
Long

Long $NSPH for .40's and beyond

NASDAQ:NSPH   NANOSPHERE INC
9 0 0
NSPH             has moderate negative correlation with larger NASX             biotech's. BIB charts implying corrective phase coming. NSPH             is a beaten down stock with good risk-reward here and I believe Verigene System (FDA cleared) could be game-changer for Nanosphere             .


A few excerpts from http://finance.yahoo.com/news/scripps-study-illustrates-clinical-economic-120000635.html :


"The statistically significant findings included a 25.7 hour reduction in time to targeted therapy (61.1 versus 35.4 hours), a 1.9 day median reduction in length of stay (9.1 versus 7.2 days) and $7,240 reduction in median hospital costs per patient ($17,530 versus $10,290)."

''A majority of health care in the U.S. is provided in community-based hospitals. These study findings demonstrate the profound impact on patient care and hospital costs the Verigene System can deliver to a wide spectrum of health care settings,' said Michael McGarrity, Nanosphere's president and chief executive officer."
Ideas Scripts Chart
United States
United Kingdom
India
España
Italia
Brasil
Россия
Türkiye
日本
한국
Home Stock Screener Economic Calendar How It Works Chart Features House Rules Moderators For the WEB Widgets Stock Charting Library Priority Support Feature Request Blog & News FAQ Help & Wiki Twitter
Private Messages Chat Ideas Published Followers Following Priority Support Public Profile Profile Settings Billing Sign Out